英菲格拉替尼(Infigratinib)2025年的正规购买渠道
Infigratinib is a targeted therapy drug targeting FGFR2 gene mutations. As an important drug for precision medicine, it provides new treatment hope for patients with FGFR2 fusions or rearrangements.
Regular purchase channels for Infigratinib in 2025
As of 2025, Infigratinib has not yet received marketing approval from the China National Medical Products Administration, nor has it been included in the scope of medical insurance reimbursement. Patients may consider purchasing the drug overseas or through online platforms.
Overseas purchases can be purchased directly with a prescription from regular pharmacies in countries where the drugs are listed, such as the United States. The quality of the drugs is guaranteed, but the cost is higher and international travel is required. This drug can be purchased online through compliant cross-border medical platforms, which is relatively economical and convenient, but it requires careful screening of platform qualifications and drug authenticity.
Will Infigratinib cause side effects
Similar to other targeted drugs, Infigratinib may cause some adverse reactions during treatment, most of which are mild to moderate.
Common adverse reactions
Patients may experience symptoms such as nail changes, oral ulcers, dry eyes, fatigue, and hair loss. These reactions are usually mild and can be relieved with symptomatic treatment. It is recommended to use lip balm to keep your mouth moist, artificial tears to relieve dry eyes, and take appropriate rest to deal with fatigue.
Abnormal laboratory indicators
Elevated serum phosphorus is the most characteristic laboratory abnormality, with a high incidence rate. Other common abnormalities include elevated serum creatinine, abnormal liver function indicators, etc. These changes are usually asymptomatic and can be detected in time through regular monitoring. Doctors will adjust drug dosage or provide symptomatic treatment if necessary.
Severe reactions that require vigilance
Retinopathy is a serious adverse reaction that requires special attention and may affect vision. Hyperphosphatemia may lead to soft tissue calcification. Regular eye examinations and blood phosphorus monitoring should be performed during treatment. If vision changes or persistent headaches occur, seek medical attention promptly.
Daily care for patients with cholangiocarcinoma
Scientific life management has positive significance for the treatment and recovery of patients with cholangiocarcinoma.
Dietary management
It is recommended to adopt a high-protein, moderate-carbohydrate diet. Eat small, frequent meals and choose foods that are easy to digest. Ensure adequate fluid intake and limit high-fat foods. If you experience loss of appetite, try nutritional supplements. Avoid raw, cold, spicy and other irritating foods.
Symptom Management
For fatigue caused by treatment, it is recommended to arrange activities and rest reasonably. Use mild moisturizing products if your skin is dry. If you have oral ulcers, choose a soft-bristled toothbrush and rinse your mouth with salty warm water. Nail changes should be avoided over-trimming and kept clean and dry.
Maintaining a positive and optimistic attitude is very important for treatment. You can communicate more with family and friends and participate in patient support groups. Seek professional psychological consultation when necessary. Moderate leisure activities and hobbies can help relieve stress.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)